The global blood viscometer market size was estimated at USD 1.62 billion in 2024 and is projected to reach USD 2.63 billion by 2033, growing at a CAGR of 5.63% from 2025 to 2033. The growth outlook by advancements in clinical diagnostics, the increasing prevalence of cardiovascular and hematological disorders, and the growing adoption of point-of-care testing technologies.
In April 2023, a study published in Clinical Hemorheology and Microcirculation examined blood rheology and nitric oxide levels in coronary artery disease patients. The findings showed that higher erythrocyte aggregation and lower NO levels were linked to poorer collateral vessel development in the heart. Innovation in blood viscometry is increasing, with modern instruments offering real-time measurement, minimal sample volume requirements, and enhanced sensitivity for non-Newtonian fluids. These advancements enable more precise rheology assessments, improve diagnostic accuracy in conditions such as diabetes, hyperviscosity syndromes, and thrombosis, and expand use in routine clinical testing.In December 2022, an article in the Biomedical Journal discussed how grounding, or direct contact with the Earth’s surface, helps lower inflammation, stabilize heart rate, and improve flow. The study noted measurable improvements in zeta potential, suggesting reduced red blood cell aggregation, a factor directly linked to viscosity and its monitoring in clinical research.
The rising incidence of cardiovascular diseases, anemia, and coagulation disorders is fueling demand for accurate viscosity measurement tools. As these disorders often involve changes in blood flow properties, viscometers are increasingly used for patient risk assessment, treatment monitoring, and therapy optimization.In February 2025, the World Health Organization (WHO) reported that anemia affects 40% of young children, 37% of pregnant women, and 30% of women of reproductive age worldwide.
The shift toward decentralized, rapid diagnostic solutions is driving demand for compact, user-friendly viscometers that deliver instant results in point-of-care settings, such as ICUs and outpatient clinics. This trend supports early disease detection, aligns with personalized medicine, and promotes cost-efficient healthcare delivery, sustaining market growth. In October 2023, a study in the Journal of Applied Physics presented a magnetic falling-sphere viscometer that employs a magnetized sphere and fluxgate magnetometers to track its motion through fluid. The system requires only 15 ml of sample and determines viscosities from 200 to 3000 cP within seconds, achieving 3% precision.
This product will be delivered within 1-3 business days.
In April 2023, a study published in Clinical Hemorheology and Microcirculation examined blood rheology and nitric oxide levels in coronary artery disease patients. The findings showed that higher erythrocyte aggregation and lower NO levels were linked to poorer collateral vessel development in the heart. Innovation in blood viscometry is increasing, with modern instruments offering real-time measurement, minimal sample volume requirements, and enhanced sensitivity for non-Newtonian fluids. These advancements enable more precise rheology assessments, improve diagnostic accuracy in conditions such as diabetes, hyperviscosity syndromes, and thrombosis, and expand use in routine clinical testing.In December 2022, an article in the Biomedical Journal discussed how grounding, or direct contact with the Earth’s surface, helps lower inflammation, stabilize heart rate, and improve flow. The study noted measurable improvements in zeta potential, suggesting reduced red blood cell aggregation, a factor directly linked to viscosity and its monitoring in clinical research.
The rising incidence of cardiovascular diseases, anemia, and coagulation disorders is fueling demand for accurate viscosity measurement tools. As these disorders often involve changes in blood flow properties, viscometers are increasingly used for patient risk assessment, treatment monitoring, and therapy optimization.In February 2025, the World Health Organization (WHO) reported that anemia affects 40% of young children, 37% of pregnant women, and 30% of women of reproductive age worldwide.
The shift toward decentralized, rapid diagnostic solutions is driving demand for compact, user-friendly viscometers that deliver instant results in point-of-care settings, such as ICUs and outpatient clinics. This trend supports early disease detection, aligns with personalized medicine, and promotes cost-efficient healthcare delivery, sustaining market growth. In October 2023, a study in the Journal of Applied Physics presented a magnetic falling-sphere viscometer that employs a magnetized sphere and fluxgate magnetometers to track its motion through fluid. The system requires only 15 ml of sample and determines viscosities from 200 to 3000 cP within seconds, achieving 3% precision.
Global Blood Viscometer Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global blood viscometer market report based on product, application, end use, and region.Product Outlook (Revenue, USD Million, 2021-2033)
- Capillary Viscometer
- Rotational Viscometer
- Vibrational / Oscillatory Viscometer
- Microfluidic Viscometer
Application Outlook (Revenue, USD Million, 2021-2033)
- Clinical Diagnostics
- Hematology & Blood Research
- Point-of-Care Testing (POCT)
End Use Outlook (Revenue, USD Million, 2021-2033)
- Hospitals & Diagnostic Laboratories
- Research & Academic Institutes
- Pharmaceutical & Biotechnology Companies
Regional Outlook (Revenue, USD Million, 2021-2033)
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa (MEA)
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Blood Viscometer Market Variables, Trends & Scope
Chapter 4. Blood Viscometer Market: Product Estimates & Trend Analysis
Chapter 5. Blood Viscometer Market: Application Estimates & Trend Analysis
Chapter 6. Blood Viscometer Market: End Use Estimates & Trend Analysis
Chapter 7. Blood Viscometer Market: Regional Estimates & Trend Analysis by Product, Application and End Use
Chapter 8. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
The key companies profiled in this Blood Viscometer market report include:- Anton Paar GmbH
- RheoSense, Inc.
- Benson Viscometers - Clinical Viscometers
- Beijing Steellex Scientific Instrument Co., Ltd.
- Health Onvector
- KYOTO ELECTRONICS MANUFACTURING CO., LTD.
- A&D Company, Limited
- AMETEK.Inc.
- Cannon Instrument Company.
- CSC Scientific Company, Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 105 |
| Published | November 2025 |
| Forecast Period | 2024 - 2033 |
| Estimated Market Value ( USD | $ 1.62 Billion |
| Forecasted Market Value ( USD | $ 2.63 Billion |
| Compound Annual Growth Rate | 5.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
